GameStop Corp. vs Nuvation Bio Inc. Class A Common Stock — how do they compare? GameStop Corp. trades at $25.31 (market cap $12.40B), while Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B). The key difference: GameStop Corp. is far larger — about 7.3× Nuvation Bio Inc. Class A Common Stock's market cap, and GameStop Corp. is trading nearer its 52-week high, Nuvation Bio Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold GameStop Corp. for 61 Days and Nuvation Bio Inc. Class A Common Stock for 0 Days on average.
| GME | NUVB | |
|---|---|---|
Market Cap | $12.40B | $1.71B |
Volume | 7,567,400 | 5,448,712 |
Sector | Consumer Cyclical | Health |
52-Week High | $26.53 | $9.54 |
52-Week Low | $17.87 | $3.41 |
Typical Hold Time | 61 Days | 0 Days |
Enterprise Value | $11.67B | $1.30B |
Signals from Pluang's Aura AI — not financial advice
GME trades at $25.28, up 2.1% on the day, with a bullish technical signal from moving averages. The company reported a net income of $131.3 million in 2025, a significant improvement from prior losses, and holds a strong cash position of $4.77 billion. Recent insider buying by CEO Ryan Cohen, including a $26.4 million purchase disclosed on September 21, 2026 (The Motley Fool), has fueled positive sentiment.
The outlook is mixed; strong cash reserves and insider confidence support upside, but declining revenue from $5.3B in 2024 to $3.8B in 2025 poses a growth risk. Analyst consensus is cautious with only 16.7% buy ratings. Key risks include execution challenges in the retail sector and high volatility typical of meme stocks.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Global Market Group Ltd. operates an Internet website that connects Chinese manufacturers with international buyers. The Company's customers can post company profiles and product information in standardized formats; post product listings; and trade leads.
Read more on GME →Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →